<- Go home

Added to YB: 2024-09-18

Pitch date: 2024-09-16

SRT.F [bullish]

Sartorius Aktiengesellschaft

+2.04%

current return

Author Info

No bio for this author

Company Info

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers.

Market Cap

EUR 11.7B

Pitch Price

EUR 185.61

Price Target

N/A

Dividend

0.39%

EV/EBITDA

21.83

P/E

154.33

EV/Sales

4.91

Sector

Life Sciences Tools and Services

Category

turnaround

Show full summary:
RGA Investment Advisors Portfolio Holding: Sartorius Aktiengesellschaft

SRT.F: Bioprocessing firm facing challenges meeting guidance, leading to share price decline. Post-COVID bottom established, industry inflection point begun. Debate over return to normalized growth, but structural growth unchanged. Long-term returns from cost basis expected to meet or exceed initial projections.

Read full article (1 min)